A cDNA microarray analysis identifies 52 genes associated with cis-diamminedichloroplatinum susceptibility in head and neck squamous cell carcinoma cell lines

European Archives of Oto-Rhino-Laryngology

Volumn 267, Issue 1, 2010, Pages 123-129

  Ogawa, Takenori ^a   Furukawa, Toru ^a   Shiga, Kiyoto ^a   Hashimoto, Sho ^a   Ogawa, Kazumi ^a   Kobayashi, Toshimitsu ^a   Horii, Akira ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CDDP; Chemosensitivity; HNSCC; Microarray

Indexed keywords

CISPLATIN; COMPLEMENTARY DNA; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CHEMOSENSITIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; GENE EXPRESSION; GENE IDENTIFICATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN GENOME; IC 50; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA; CELL LINE, TUMOR; CISPLATIN; DNA, COMPLEMENTARY; DNA, NEOPLASM; FLOW CYTOMETRY; GENES, NEOPLASM; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASMS, SQUAMOUS CELL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 71349088476     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-009-0976-x     Document Type: Article

References (28)

1. RI Haddad DM Shin 2008 Recent advances in head and neck cancer N Engl J Med 359 1143 1154 10.1056/NEJMra0707975 10.1056/NEJMra0707975 1:CAS:528:DC%2BD1cXhtFWrsLvI 18784104
2. B Rosenberg L VanCamp JE Trosko VH Mansour 1969 Platinum compounds: a new class of potent antitumour agents Nature 222 385 386 10.1038/222385a0 10.1038/222385a0 1:CAS:528:DyaF1MXktVWquro%3D 5782119
3. Rosenberg B (1999) Platinum complexes for the treatment of cancer: why the search goes on, in cisplatin. In: Lippert B (ed) Chemistry and biochemistry of a leading anticancer drug. Wiley-VCH, Basel, pp 3-27
4. DJ Adelstein Y Li GL Adams, et al. 2003 An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 92 98 10.1200/JCO.2003.01.008 10.1200/JCO.2003.01.008 12506176
5. AA Forastiere H Goepfert M Maor, et al. 2003 Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2091 2098 10.1056/NEJMoa031317 10.1056/NEJMoa031317 1:CAS:528: DC%2BD3sXptlKiu7s%3D 14645636 (Pubitemid 37464533)
6. J Bernier C Domenge M Ozsahin, et al. 2004 European Organization for Research and Treatment of Cancer Trial 22931: postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 1945 1952 10.1056/NEJMoa032641 10.1056/NEJMoa032641 1:CAS:528:DC%2BD2cXjslehsrk%3D 15128894 (Pubitemid 38580197)
7. PA Andrews SB Howell 1990 Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance Cancer Cells 2 35 43 1:CAS:528:DyaK3cXhvFWiurs%3D 2204382
8. LK Hosking RD Whelan SA Shellard P Bedford BT Hill 1990 An evaluation of the role of glutathione and its associated enzymes in the expression of differential sensitivities to antitumor agents shown by a range of human tumour cell lines Biochem Pharmacol 40 1833 1842 10.1016/0006-2952(90)90364-Q 10.1016/0006-2952(90)90364-Q 1:CAS:528:DyaK3MXhslahuw%3D%3D 2242017 (Pubitemid 20337966)
9. GA Hospers C Meijer L de Leij DR Uges NH Mulder EG de Vries 1990 A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance Int J Cancer 46 138 144 10.1002/ijc.2910460125 10.1002/ijc.2910460125 1:CAS:528:DyaK3MXhtFClur8%3D 2163989 (Pubitemid 20225800)
10. C Meijer NH Mulder H Timmer-Bosscha WJ Sluiter GJ Meersma EG de Vries 1992 Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds Cancer Res 52 6885 6889 1:CAS:528:DyaK3sXlt1SjtA%3D%3D 1458477
11. M Schena D Shalon R Heller A Chai PO Brown RW Davis 1996 Parallel human genome analysis: microarray-based expression monitoring of 1,000 genes Proc Natl Acad Sci USA 93 10614 10619 10.1073/pnas.93.20.10614 10.1073/pnas.93.20.10614 1:CAS:528:DyaK28XmtVOlsbo%3D 8855227 (Pubitemid 26333036)
12. H Zembutsu Y Ohnishi T Tsunoda, et al. 2002 Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs Cancer Res 62 518 527 1:CAS:528: DC%2BD38XhtVyht7c%3D 11809704
13. E Higuchi N Oridate Y Furuta, et al. 2003 Differentially expressed genes associated with CIS-diamminedichloroplatinum (II) resistance in head and neck cancer using differential display and cDNA microarray Head Neck 25 187 193 10.1002/hed.10204 10.1002/hed.10204 12599285 (Pubitemid 36245876)
14. LQ Jia M Osada C Ishioka, et al. 1997 Screening the p53 status of human cell lines using a yeast functional assay Mol Carcinog 19 243 253 10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D 10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D 1:CAS:528:DyaK2sXlslWlsbw%3D 9290701 (Pubitemid 27392003)
15. T Mosmann 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 65 55 63 10.1016/0022-1759(83)90303-4 10.1016/0022-1759(83)90303-4 1:STN:280: DyaL2c%2FovFSmtw%3D%3D 6606682
16. T Hata T Furukawa M Sunamura, et al. 2005 RNA interference targeting aurora kinase A suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells Cancer Res 65 2899 2905 10.1158/0008-5472.CAN- 04-3981 10.1158/0008-5472.CAN-04-3981 1:CAS:528:DC%2BD2MXjtVeqt70%3D 15805292 (Pubitemid 40490094)
17. T Ogawa K Shiga S Hashimoto T Kobayashi A Horii T Furukawa 2003 APAF-1-ALT, a novel alternative splicing form of APAF-1, potentially causes impeded ability of undergoing DNA damage-induced apoptosis in the LNCaP human prostate cancer cell line Biochem Biophys Res Commun 306 537 543 10.1016/S0006-291X(03)00995-1 10.1016/S0006-291X(03)00995-1 1:CAS:528: DC%2BD3sXksVyktLs%3D 12804598 (Pubitemid 36683108)
18. E Kondo A Horii S Fukushige 1999 The human PMS2L proteins do not interact with hMLH1, a major DNA mismatch repair protein J Biochem 125 818 825 1:CAS:528:DyaK1MXjsVyrtbY%3D 10101297
19. S Yamanaka M Sunamura T Furukawa, et al. 2004 Chromosome 12, frequently deleted in human pancreatic cancer, may encode a tumor-suppressor gene that suppresses angiogenesis Lab Invest 84 1339 1351 10.1038/labinvest.3700160 10.1038/labinvest.3700160 1:CAS:528:DC%2BD2cXovVaitr0%3D 15300227 (Pubitemid 40063698)
20. Y Mori H Shiwaku S Fukushige, et al. 1997 Alternative splicing of hMSH2 in normal human tissues Hum Genet 99 590 595 10.1007/s004390050411 10.1007/s004390050411 1:CAS:528:DyaK2sXjtl2ltb4%3D 9150723 (Pubitemid 27192587)
21. DE Fisher 1994 Apoptosis in cancer therapy: crossing the threshold Cell 78 539 542 10.1016/0092-8674(94)90518-5 10.1016/0092-8674(94)90518-5 1:STN:280:DyaK2czkvFemtQ%3D%3D 8069905 (Pubitemid 24268576)
22. NA Jones J Turner AJ McIlwrath R Brown C Dive 1998 Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between Bax and Bak up-regulation and the functional status of p53 Mol Pharmacol 53 819 826 1:CAS:528:DyaK1cXjsFSjtbY%3D 9584207
23. AJ Raffo AL Kim RL Fine 2000 Formation of nuclear Bax/p53 complexes is associated with chemotherapy-induced apoptosis Oncogene 19 6216 6228 10.1038/sj.onc.1203995 10.1038/sj.onc.1203995 1:CAS:528:DC%2BD3MXnslejtw%3D%3D 11175336 (Pubitemid 32641835)
24. VM Gonzalez MA Fuertes C Alonso JM Perez 2001 Is cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol 59 657 663 1:CAS:528:DC%2BD3MXisVSru70%3D 11259608
25. S Fulda M Los C Friesen KM Debatin 1998 Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system Int J Cancer 76 105 114 10.1002/(SICI)1097-0215(19980330)76:1<105::AID-IJC17>3.0.CO;2-B 10.1002/(SICI)1097-0215(19980330)76:1<105::AID-IJC17>3.0.CO;2-B 1:CAS:528:DyaK1cXit12qtLw%3D 9533769 (Pubitemid 28164576)
26. X Wang JL Martindale NJ Holbrook 2000 Requirement for ERK activation in cisplatin-induced apoptosis J Biol Chem 275 39435 39443 10.1074/jbc.M004583200 10.1074/jbc.M004583200 1:CAS:528:DC%2BD3cXptFSrtr0%3D 10993883 (Pubitemid 32058968)
27. JM Pérez EI Montero AM González A Alvarez-Valdés C Alonso C Navarro-Ranninger 1999 Apoptosis induction and inhibition of H-ras overexpression by novel trans-[PtCl2(isopropylamine)(amine')] complexes J Inorg Biochem 77 37 42 10.1016/S0162-0134(99)00143-9 10.1016/S0162-0134(99)00143-9 10626351 (Pubitemid 30089079)
28. KT Robbins P Kumar J Harris, et al. 2005 Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615 J Clin Oncol 23 1447 1454 10.1200/JCO.2005.03.168 10.1200/JCO.2005.03.168 1:CAS:528:DC%2BD2MXis1Gnu7c%3D 15735120 (Pubitemid 46260032)